Curriculum Vitae of Mrs Michelle Viljoen
Faculty Health Sciences: School of Pharmacy
Private Bag X6001, Potchefstroom South Africa, 2520
North-West University (NWU) Potchefstroom Campus 11 Hoffman street Building G16, Room 113 Potchefstroom, 2531
3. Qualifications (Start with most recent)
4. Employment history (From current backwards. Not more than five)
Primary Health Care Clinics). Health and Training
Consultant. Session locum at Potchefstroom Provincial Hospital
Pharmacogenetics and Pharmacokinetics of Antiretroviral drugs
Pharmacogenetics and Pharmacokinetics of Antiretroviral drugs
6. Publications (List publications over the last three years)
Viljoen, M. Loots, DT. Rheeders, M. Gous, HS. Routine drug
level monitoring of first line ARV regimen in a South African paediatric HIV roll-out clinic. The Canadian Journal of Clinical Pharmacology, 2008 15 (3):e753.
Viljoen M, Gous H, Kruger HS, Riddick A, Meyers TM,
Rheeders M. Efavirenz Plasma Concentrations at 1, 3 and 6 Months Post Antiretroviral Therapy Initiation in HIV-1 Infected South African Children. Aids Research and Human Retroviruses, 2010 26(6):
Viljoen, M. Meyer, CL. Lubbe, MS. The prevalence of side-
effects: Ciprofloxacin 500 mg single dose prophylaxis against Neisseria Meningitidis outbreak in Potchefstroom during July 2003. Health SA Gesondheid: 2004 9 (3):42-54.
7. Papers delivered (List papers over the last three years)
Viljoen, M. Loots, DT. Rheeders, M. Gous, HS. Routine drug
level monitoring of first line ARV regimen in a South African paediatric HIV roll-out clinic. IXth World Conference on Clinical Pharmacology and Therapeutics, 27July-1 Aug. 2008, Quebec, Canada. (Poster)
Viljoen, M. Gous, H. Kruger, H.S. Riddick, A. & Rheeders, M.
Efavirenz plasma concentrations at 1,3 and 6 months post antiretroviral treatment in HIV-1 infected South African children. Ist International Workshop HIV Peditarics, 17-18 July 2009, Cape Town, South Africa . (Poster)
Kruger, H.S. Viljoen, M. Gous, Haupt, C. Improvement in
nutritional status of HIV-infected children after starting highly active antiretroviral therapy. Ist International Workshop HIV Peditarics, 17-18 July 2009, Cape Town, South Africa . (Poster)
Theron, A. Viljoen, M. Rheeders. A pilot study to investigate
the predictability of efavirenz plasma levels in HIV-1 infected South African children. 5th International Conference on Pharmaceutical and Pharmacological Sciences (ICPPS), 23- 26 September 2009, North-West University, Potchefstroom Campus (Podium).
Kruger, HS, Viljoen, M. Haupt, C, Meyers, TM. Improved body
composition of HIV-1 infected stunted children after one year of antiretroviral therapy. IUNS 5-8 October 2009, Bangkok, Thailand. (Poster)
Viljoen M, Theron A, Cromarty D, Rheeders M, Jansen van
Rensburg PJ, Malan L. Determination of efavirenz in human saliva by high performance liquid chromatography coupled with
International Workshop on HIV Peditarics, 16-17 July 2010, Vienna, Austria. (Poster)
Viljoen M, Dandara C, Rheeders M, Conradie KR, Kruger HS,
Meyers TM, Gous H. Prevalence of CYP2B6-516G>T polymorphism in black South African HIV-infected children on efavirenz based antiretroviral therapy. 16TH World Congress of Basic and Clinical Pharmacology, 17-23 July 2010, Copenhagen, Denmark. (Poster)
Rheeders M, Viljoen M, Theron M, Meyers TM. Saliva as a
non-invasive alternative to plasma efavirenz. 16TH World Congress of Basic and Clinical Pharmacology, 17-23 July 2010, Copenhagen, Denmark. (Poster)
Viljoen, M. Meyer, CL. Lubbe, MS. The prevalence of side-effects: Ciprofloxacin 500 mg single dose prophylaxis against Neisseria Meningitidis outbreak in Potchefstroom during July 2003. 38th Annual Congress South African Pharmacological Society, October 2004 (Poster).
Du Plooy M., Rheeders, M. & Viljoen, M. 2008. Investigating the effect of P-glycoprotein (P-gp) inhibition in blood levels on the metabolism of selective antiretroviral drugs, in Sprague-Dawley rats. South African Society for Basic and Clinical Pharmacology, Rhodes University, Grahamstown, South Africa, 5-8 October 2008. (Podium)
SER30E – SER30 – SER30P ITALIANO 1. Definizione prodotto Centralina per il controllo di 1 motore da utilizzare per la movimentazione di serrande, con potenza massima di 500W. La centralina nella versione SER30E è dotata di ricevitore radio 433.920 MHZ e di una memoria EEPROM con capacità di 50 utenti, ed è in grado di operare con tutti i trasmettitori delle famiglie
Tävlingsbestämmelser 2012 Skandia Tour är ett toursystem i vilket alla juniorer 13-21 år kan tävla i golf på olika nivåer. Skandia Tour genomförs som individuella tävlingar på fyra nivåer, Elit, Riks, Regional och Distrikt. På samtliga spelplatser och nivåer har flickor och pojkar gemensamma spelplatser. Mellan varje omgång sker uppflyttningar baserat på prestation. Skandi